Glaxosmithkline | GSK

Stock Price
40.50
Daily Change
0.89 2.25%
Monthly
10.20%
Yearly
-7.26%
Q3 Forecast
40.28

Peers Price Chg Day Year Date
Takeda 4,574.00 33.00 0.73% 7.09% Sep/05
AbbVie 212.56 -0.44 -0.21% 9.95% Sep/05
Aurora Cannabis 6.78 0.09 1.35% -7.50% Sep/05
Amgen 283.64 3.54 1.26% -11.49% Sep/05
AstraZeneca 12,090.00 -98.00 -0.80% -4.89% Sep/06
Bristol-Myers Squibb 47.14 0.45 0.96% -3.28% Sep/05
Corcept Therapeutics 69.36 -0.01 -0.01% 101.75% Sep/05
Glaxosmithkline 40.50 0.89 2.25% -7.26% Sep/05
J&J 178.43 -0.33 -0.18% 8.51% Sep/05
Eli Lilly 727.21 -15.70 -2.11% -19.48% Sep/05
Merck 84.71 0.66 0.79% -28.14% Sep/05
Novartis 103.98 0.06 0.06% 5.46% Sep/05
Prestige Brands 65.05 -1.70 -2.55% -12.50% Sep/05
Pacira 26.45 -0.28 -1.05% 90.97% Sep/05
Pfizer 24.88 0.34 1.39% -12.95% Sep/05
Perrigo 23.49 -0.25 -1.05% -19.14% Sep/02
Drreddys Laboratories 14.34 0.19 1.34% -81.89% Sep/05
Roche Holding 274.20 -1.50 -0.54% 2.62% Sep/06
Sanofi 79.50 0.54 0.68% -24.83% Sep/06
Supernus Pharmaceuticals 46.00 0.57 1.25% 35.93% Sep/05
Teva Pharmaceutical Industries 6,275.00 -65.00 -1.03% -9.12% Sep/04
Bausch Health Companies 10.18 0.20 2.00% 20.90% Sep/05
Canopy Growth 2.02 0.11 5.76% -66.72% Sep/05
Zoetis 153.32 0.12 0.08% -19.13% Sep/05


Glaxosmithkline traded at $40.50 this Friday September 5th, increasing $0.89 or 2.25 percent since the previous trading session. Looking back, over the last four weeks, Glaxosmithkline gained 10.20 percent. Over the last 12 months, its price fell by 7.26 percent. Looking ahead, we forecast Glaxosmithkline to be priced at 40.28 by the end of this quarter and at 39.63 in one year, according to Trading Economics global macro models projections and analysts expectations.

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.